neostigmine has been researched along with alfentanil in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bourgain, JL; Hacman, H; Meistelman, C; Truffa-Bachi, J | 1 |
Eisenach, JC; Hood, DD; James, RL; Mallak, KA; Tuttle, R | 1 |
de Francisci, G; Iacobucci, T; Nanni, L; Picoco, F | 1 |
4 other study(ies) available for neostigmine and alfentanil
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
[Changes in heart rate after administration of neostigmine as a function of the morphinomimetic used].
Topics: Adult; Alfentanil; Analgesics, Opioid; Fentanyl; Heart Rate; Humans; Middle Aged; Neostigmine | 1989 |
Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition.
Topics: Acetylcholine; Adult; Alfentanil; Analgesia; Analgesics, Opioid; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Nausea; Neostigmine; Respiration; Spinal Cord | 1997 |
Anesthesia for a child with Wolf-Hirshhorn syndrome.
Topics: Abnormalities, Multiple; Alfentanil; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Anti-Inflammatory Agents, Non-Steroidal; Atracurium; Child, Preschool; Chromosome Deletion; Chromosome Disorders; Circumcision, Male; Humans; Intubation, Intratracheal; Ketorolac; Male; Methyl Ethers; Neostigmine; Neuromuscular Blocking Agents; Parasympathomimetics; Sevoflurane; Syndrome | 2004 |